Related Experiment Video
Updated: Jul 5, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycemic Variability As a Prognostic Factor for Mortality in Patients With Critical Illness: A Systematic Review and
Brett N Hryciw1, Jamie Ghossein2, Bram Rochwerg3
1Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Increased glycemic variability, including standard deviation and decreased time in range, is linked to higher short-term mortality in critically ill patients. Further research is needed for standardized measurements and therapeutic targets.
Area of Science:
- Critical care medicine
- Endocrinology
- Biostatistics
Background:
- Glycemic variability is a key concern in critical care.
- Understanding its association with mortality is crucial for patient outcomes.
Purpose of the Study:
- To systematically review and meta-analyze the link between glycemic variability metrics and short-term mortality in critically ill patients.
- To evaluate both time-domain and complexity-domain measures of glycemic variation.
Main Methods:
- Searched Embase, MEDLINE, and Cochrane databases up to November 3, 2023.
- Included 41 studies with 162,259 patients assessing glycemic variation and short-term ICU mortality.
- Used random-effects models for meta-analysis and assessed study quality and evidence certainty.
Main Results:
- Increased standard deviation, coefficient of variance, and glycemic lability index were probably associated with higher mortality (moderate certainty).
- Decreased time in range was also probably linked to increased mortality.
- Increased mean absolute glucose, mean amplitude of glycemic excursion, and detrended fluctuation analysis may be associated with increased mortality (low certainty).
Conclusions:
- A consistent association exists between elevated glycemic variability measures and increased short-term mortality in critically ill patients.
- Standardized measurement of glycemic variation and complexity is recommended.
- Further research should explore their role as therapeutic targets and prognostic markers.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Acute Pancreatitis II: Clinical Manifestations and Management
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...